These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 12534607)

  • 1. Efficacy of betamethasone valerate mousse in comparison with standard therapies on scalp psoriasis: an open, multicentre, randomized, controlled, cross-over study on 241 patients.
    Andreassi L; Giannetti A; Milani M;
    Br J Dermatol; 2003 Jan; 148(1):134-8. PubMed ID: 12534607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of betamethasone valerate 0.1% thermophobic foam in seborrhoeic dermatitis of the scalp: an open-label, multicentre, prospective trial on 180 patients.
    Milani M; Antonio Di Molfetta S; Gramazio R; Fiorella C; Frisario C; Fuzio E; Marzocca V; Zurilli M; Di Turi G; Felice G
    Curr Med Res Opin; 2003; 19(4):342-5. PubMed ID: 12841928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial.
    Kragballe K; Hoffmann V; Ortonne JP; Tan J; Nordin P; Segaert S
    Br J Dermatol; 2009 Jul; 161(1):159-66. PubMed ID: 19416259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scalp psoriasis: topical calcipotriol 50 micrograms/g/ml solution vs. betamethasone valerate 1% lotion.
    Duweb GA; Abuzariba O; Rahim M; al-Taweel M; Abdulla SA
    Int J Clin Pharmacol Res; 2000; 20(3-4):65-8. PubMed ID: 11314240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study.
    Buckley C; Hoffmann V; Shapiro J; Saari S; Cambazard F; Milsgaard M
    Dermatology; 2008; 217(2):107-13. PubMed ID: 18463448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life in patients with scalp psoriasis treated with calcipotriol/betamethasone dipropionate scalp formulation: a randomized controlled trial.
    Ortonne JP; Ganslandt C; Tan J; Nordin P; Kragballe K; Segaert S
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):919-26. PubMed ID: 19453810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical treatment for scalp psoriasis: Comparison of patient preference, quality of life and efficacy for non-alcoholic mometasone emulsion versus calcipotriol/betamethasone gel in daily clinical practice.
    Gual A; Pau-Charles I; Molin S
    J Dermatolog Treat; 2016; 27(3):228-34. PubMed ID: 26503824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Betamethasone valerate in foam vehicle is effective with both daily and twice a day dosing: a single-blind, open-label study in the treatment of scalp psoriasis.
    Feldman SR; Ravis SM; Fleischer AB; McMichael A; Jones E; Kaplan R; Shavin J; Weiss J; Bartruff JK; Levin DL; Del Rosso J; Kpea N
    J Cutan Med Surg; 2001; 5(5):386-9. PubMed ID: 11907847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
    van de Kerkhof PC; Hoffmann V; Anstey A; Barnes L; Bolduc C; Reich K; Saari S; Segaert S; Vaillant L
    Br J Dermatol; 2009 Jan; 160(1):170-6. PubMed ID: 19067709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of safety and efficacy between calcipotriol plus betamethasone dipropionate gel and calcipotriol scalp solution as long-term treatment for scalp psoriasis in Chinese patients: a national, multicentre, prospective, randomized, active-controlled phase 4 trial.
    Liu L; Zhang C; Wang J; Chen K; Ding Y; Yan G; Lu Q; Li W; Fang H; Cheng H; Zhang J; He Y; Zhu W; Lu Y; Huang J; Pan W; Li M; Cao S; Li S; Han X; He L; Chen Y; Zheng M
    Eur J Dermatol; 2020 Oct; 30(5):580-590. PubMed ID: 33052103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind clinical study reveals synergistic action between alpha-hydroxy acid and betamethasone lotions towards topical treatment of scalp psoriasis.
    Kostarelos K; Teknetzis A; Lefaki I; Ioannides D; Minas A
    J Eur Acad Dermatol Venereol; 2000 Jan; 14(1):5-9. PubMed ID: 10877245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of calcipotriol solution (50 micrograms/ml) and betamethasone 17-valerate solution (1 mg/ml) in the treatment of scalp psoriasis.
    Klaber MR; Hutchinson PE; Pedvis-Leftick A; Kragballe K; Reunala TL; Van de Kerkhof PC; Johnsson MK; Molin L; Corbett MS; Downess N
    Br J Dermatol; 1994 Nov; 131(5):678-83. PubMed ID: 7999600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study. Calcipotriol Study Group.
    Molin L; Cutler TP; Helander I; Nyfors B; Downes N
    Br J Dermatol; 1997 Jan; 136(1):89-93. PubMed ID: 9039301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of tazarotene 0.1% gel once daily plus mometasone furoate 0.1% cream once daily versus calcipotriene 0.005% ointment twice daily in the treatment of plaque psoriasis.
    Guenther LC; Poulin YP; Pariser DM
    Clin Ther; 2000 Oct; 22(10):1225-38. PubMed ID: 11110233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of calcipotriol monotherapy and a combination of calcipotriol and betamethasone valerate after 2 weeks' treatment with calcipotriol in the topical therapy of psoriasis vulgaris: a multicentre, double-blind, randomized study.
    Ruzicka T; Lorenz B
    Br J Dermatol; 1998 Feb; 138(2):254-8. PubMed ID: 9602870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatments for scalp psoriasis with emphasis on calcipotriol plus betamethasone dipropionate gel (Xamiol).
    Guenther LC
    Skin Therapy Lett; 2009 May; 14(4):1-4. PubMed ID: 19585059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam Compared with Betamethasone 17-Valerate-Medicated Plaster for the Treatment of Psoriasis.
    Queille-Roussel C; Rosen M; Clonier F; Nørremark K; Lacour JP
    Clin Drug Investig; 2017 Apr; 37(4):355-361. PubMed ID: 27995521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of calcipotriene plus betamethasone dipropionate topical suspension in the treatment of extensive scalp psoriasis in adolescents ages 12 to 17 years.
    Eichenfield LF; Ganslandt C; Kurvits M; Schlessinger J
    Pediatr Dermatol; 2015; 32(1):28-35. PubMed ID: 25412565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial.
    Guenther L; Van de Kerkhof PC; Snellman E; Kragballe K; Chu AC; Tegner E; Garcia-Diez A; Springborg J
    Br J Dermatol; 2002 Aug; 147(2):316-23. PubMed ID: 12174105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcipotriol plus betamethasone dipropionate gel compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized, controlled trial investigating efficacy and safety in a Chinese population.
    Ma L; Yang Q; Yang H; Wang G; Zheng M; Hao F; Gu J; Sun Q; Cui P; Ge M; Li R; Gao T; Facy P; Kurvits M; Xu Z; Xu J
    Int J Dermatol; 2016 Jan; 55(1):106-13. PubMed ID: 26094549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.